Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07709598Phase 3Recruiting
A Phase 3 trial of HL-1186 in postoperative pain, sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started May 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07709598.